PREMIER ANTI-AGING CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 921 JPY | -0.75% |
|
+6.11% | -8.90% |
Valuation
| Fiscal Period: July | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 132,631 | 17,397 | 9,331 | 8,031 | - | - |
| Enterprise Value (EV) 1 | 127,480 | 15,837 | 6,825 | 8,031 | 8,031 | 8,031 |
| P/E ratio | 46.5 x | 12.2 x | -12.7 x | -3.87 x | -20.2 x | 38.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 4.04 x | 0.51 x | 0.35 x | 0.4 x | 0.42 x | 0.4 x |
| EV / Revenue | 4.04 x | 0.51 x | 0.35 x | 0.4 x | 0.42 x | 0.4 x |
| EV / EBITDA | - | 6.96 x | -21.8 x | -21.7 x | -803 x | 11.5 x |
| EV / FCF | - | -4.81 x | 6.13 x | -8.38 x | -21.7 x | 57.4 x |
| FCF Yield | - | -20.8% | 16.3% | -11.9% | -4.61% | 1.74% |
| Price to Book | 19.2 x | 2.08 x | 1.23 x | 1.46 x | 1.56 x | 1.49 x |
| Nbr of stocks (in thousands) | 8,720 | 8,720 | 8,720 | 8,720 | - | - |
| Reference price 2 | 15,210 | 1,995 | 1,070 | 928.0 | 928.0 | 928.0 |
| Announcement Date | 21-09-14 | 22-09-13 | 23-09-14 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: July | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 32,815 | 33,912 | 26,401 | 19,850 | 19,350 | 20,150 |
| EBITDA 1 | - | 2,500 | -427.6 | -370 | -10 | 700 |
| EBIT 1 | 4,680 | 2,414 | -611.7 | -600 | -250 | 450 |
| Operating Margin | 14.26% | 7.12% | -2.32% | -3.02% | -1.29% | 2.23% |
| Earnings before Tax (EBT) | 4,653 | 2,572 | -659.5 | - | - | - |
| Net income 1 | 2,793 | 1,424 | -734 | -2,090 | -400 | 210 |
| Net margin | 8.51% | 4.2% | -2.78% | -10.53% | -2.07% | 1.04% |
| EPS 2 | 326.9 | 163.4 | -84.17 | -239.7 | -45.90 | 24.10 |
| Free Cash Flow 1 | - | -3,620 | 1,522 | -958 | -370 | 140 |
| FCF margin | - | -10.67% | 5.76% | -4.83% | -1.91% | 0.69% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 20% |
| FCF Conversion (Net income) | - | - | - | - | - | 66.67% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 21-09-14 | 22-09-13 | 23-09-14 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: July | 2021 S1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 15,310 | 8,105 | 17,970 | 7,927 | 8,014 | 7,391 | 6,868 | 14,259 | 6,351 | 5,791 | 5,264 | 5,385 | 10,649 | 4,790 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 2,461 | 174 | 2,248 | -290.9 | 456.9 | -244 | 353 | 109 | -66.49 | -654.2 | -35 | -170 | -205 | 208 |
| Operating Margin | 16.07% | 2.15% | 12.51% | -3.67% | 5.7% | -3.3% | 5.14% | 0.76% | -1.05% | -11.3% | -0.66% | -3.16% | -1.93% | 4.34% |
| Earnings before Tax (EBT) 1 | 2,454 | - | 2,321 | -180.3 | 431.3 | -224 | 319.2 | 95.24 | -51.79 | -674.7 | -26 | -1,082 | -1,108 | 244 |
| Net income 1 | 1,573 | 40 | 1,360 | -138 | 202 | -198 | 172 | -26.01 | -127.3 | -580.7 | -35 | -1,650 | -1,685 | 235 |
| Net margin | 10.27% | 0.49% | 7.57% | -1.74% | 2.52% | -2.68% | 2.5% | -0.18% | -2% | -10.03% | -0.66% | -30.64% | -15.82% | 4.91% |
| EPS 2 | 187.8 | - | 156.0 | -15.83 | - | -22.71 | - | -2.980 | -14.60 | - | -4.090 | - | -193.2 | 26.88 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 21-03-15 | 22-03-14 | 22-03-14 | 22-06-13 | 22-09-13 | 22-12-14 | 23-03-14 | 23-03-14 | 23-06-14 | 23-09-14 | 23-12-14 | 24-03-14 | 24-03-14 | 24-06-13 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: July | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | 5,151 | 1,560 | 2,506 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -3,620 | 1,522 | -958 | -370 | 140 |
| ROE (net income / shareholders' equity) | 66.9% | 18.7% | -9.2% | - | - | 4% |
| ROA (Net income/ Total Assets) | - | 11.2% | -5.2% | - | - | 2.1% |
| Assets 1 | - | 12,686 | 14,115 | - | - | 10,000 |
| Book Value Per Share 2 | 792.0 | 957.0 | 873.0 | 635.0 | 594.0 | 623.0 |
| Cash Flow per Share | 332.0 | 173.0 | -63.00 | - | - | - |
| Capex 1 | 12 | 112 | 27.1 | 190 | 200 | 210 |
| Capex / Sales | 0.04% | 0.33% | 0.1% | 0.96% | 1.03% | 1.04% |
| Announcement Date | 21-09-14 | 22-09-13 | 23-09-14 | - | - | - |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
928
JPY
Average target price
830
JPY
Spread / Average Target
-10.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.90% | 50.31M | |
| -7.87% | 235B | |
| 0.00% | 19.58B | |
| +11.57% | 18.85B | |
| +8.42% | 11.4B | |
| -18.40% | 8.65B | |
| +15.38% | 7.45B | |
| +11.66% | 6.03B | |
| -6.81% | 3.87B | |
| -17.92% | 3.72B |
- Stock Market
- Equities
- 4934 Stock
- Financials Premier Anti-Aging Co., Ltd.
